![Todd Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 441 526 $ al 31/07/2026
Todd Carter is currently Chief Scientific Officer at Voyager Therapeutics, Inc. since 2022.
Formerly, Dr. Carter was Senior Director-Biology at BrainCells, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Texas A&M University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/02/2026 | 145.718 ( 0,24 % ) | 441 526 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/11/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
